Abbott Laboratories (XSGO:ABT) EV-to-EBITDA : 19.52 (As of Apr. 24, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Abbott Laboratories EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Abbott Laboratories's enterprise value is $195,037 Mil. Abbott Laboratories's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $9,992 Mil. Therefore, Abbott Laboratories's EV-to-EBITDA for today is 19.52.

The historical rank and industry rank for Abbott Laboratories's EV-to-EBITDA or its related term are showing as below:

XSGO:ABT' s EV-to-EBITDA Range Over the Past 10 Years
Min: 12.15 Med: 19.7 Max: 29.25
Current: 19.52

During the past 13 years, the highest EV-to-EBITDA of Abbott Laboratories was 29.25. The lowest was 12.15. And the median was 19.70.

XSGO:ABT's EV-to-EBITDA is ranked worse than
62.42% of 487 companies
in the Medical Devices & Instruments industry
Industry Median: 15.1 vs XSGO:ABT: 19.52

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-24), Abbott Laboratories's stock price is $112.41. Abbott Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $3.210. Therefore, Abbott Laboratories's PE Ratio for today is 35.02.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Abbott Laboratories EV-to-EBITDA Historical Data

The historical data trend for Abbott Laboratories's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories EV-to-EBITDA Chart

Abbott Laboratories Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBITDA

Get a 7-Day Free Trial

21.65

23.37

20.95

16.37

18.92

Abbott Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBITDA	Get a 7-Day Free Trial															16.97	19.59	17.58	18.92	-

Competitive Comparison of Abbott Laboratories's EV-to-EBITDA

For the Medical Devices subindustry, Abbott Laboratories's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abbott Laboratories's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's EV-to-EBITDA falls into.

Abbott Laboratories EV-to-EBITDA Calculation

Abbott Laboratories's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	195037.478	/	9992
	=	19.52

Abbott Laboratories's current Enterprise Value is $195,037 Mil.
Abbott Laboratories's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $9,992 Mil.

Abbott Laboratories (XSGO:ABT) EV-to-EBITDA Explanation

Abbott Laboratories's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	112.41	/	3.210
	=	35.02

Abbott Laboratories's share price for today is $112.41.
Abbott Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.210.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Abbott Laboratories EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbott Laboratories (XSGO:ABT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (XSGO:ABT) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

ABT:USA ABT:Mexico 0Q15:UK ABL:Germany ABT:Switzerland ABTT34:Brazil ABT:Austria ABT:Argentina

Address

100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400

Website

https://www.abbottinvestor.com

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.